跳至主要内容
临床试验/ISRCTN21432643
ISRCTN21432643已完成不适用

To study the effect of collagen cross-linking (CXL) as a primary treatment for bacterial keratitis in two ophthalmological centres, through a non-randomised clinical pilot study of twenty patients

Clinical Research Support (CRS) Centre, Örebro (Sweden)0 个研究点目标入组 20 人开始时间: 2010年1月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • To be included in the study all patients must fulfil the following criteria:
  • 1. Suspected bacterial keratitis
  • 2. Aged 18 years or above, either sex
  • 3. Signed informed consent

排除标准

  • 1. Any antibiotic treatment for the current episode of keratitis
  • 2. Suspicion of a non-bacterial keratitis
  • 3. Pachymetry values under 400 mm
  • 4. Pregnancy or breast-feeding
  • 5. Allergy towards riboflavin or any substance in Ricrolin®
  • 6. Participation in any ophthalmological study in which the follow-up is not completed
  • 7. The patient might not be able to complete the follow-up after treatment required in the study

研究者

发起方
Clinical Research Support (CRS) Centre, Örebro (Sweden)

相似试验